Reorganization of the cardiac gap junctions in adriamycin-induced cardiomyopathy  by Plenz, Gabriele et al.
C3 
co 
g 
136A ABSTRACTS - Cardiac Function and Heart Failure 
1038-147 Treatment of AL Cardiac Amyloidosis With Intravenous 
High-DoN Melphalan and Stem Cell Transplantation 
Jina Chuna, Vaishali Sanchorawala, Martha Skinner, Rodney H. FaJk, Boston Medical 
Center, Boston, Massachusetts. 
Background: Primary systemic amyloidosis (AL) with cardiac involvement is rapidly pro- 
gressive and, if untreated, has a median survival of about six months. Intravenous high- 
dose melphalan chemotherapy with stem cell transplantation (HDM/SCT) can induce 
hematological remission (HR) in AL amyloid patients. However, cardiac involvement sig- 
nificantly increases therapy-related morbidity and mortality and the risk-to-benefit ratio is 
unknown. 
Methods: 95 patients with biopsy-proven AL amyloidosis and cardiac involvement (age, 
55 +13 years) were treated with HDM/SCT and compared to 143 similarly treated non- 
cardiac amyloid patients (age, 57 +10 years). 
Results: One-year survival was 88% in non-cardiac patients and 49% in cardiac patients 
(p < 0.000001). In the cardiac group, those with congestive heart failure (CHF) at base- 
line (51%) had decreased 1-year survival compared to those without CHF (40% vs. 58%, 
p = 0.07). Among 39 cardiac patients who survived 1 year after therapy, 44% achieved 
HR. At 2 years, there was a strong trend to improved survival among cardiac patients in 
HR compared to those not in HR (78% vs. 64%, p = 0.10). 
Conclusions: Cardiac involvement in AL amyloidosis is associated with worse outcome 
after HDM/SCT, particularly if CHF is present. HR among survivors I year after therapy is 
a marker of better intermediate-term prognosis than persistent hematological disease. 
However, some patients in HR still die, presumably due to complications of severe pre- 
existing amyloid heart disease. 
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1038-148 Echocardiographic Features of Constrictive Pericarditis 
in the Setting of Severe Tricuspid Regurgitation 
Richard Y. Bae, Jae K. Oh, Jong-Won Ha, Marion E. Barnes, Lieng H. Ling, A Jamil Tajik, 
Mayo Clinic, Rochester, Minnesota. 
Background. Two-dimensional (2D) and Doppler echocardiographic features of con- 
stdctive pericarditis (CP) have been well described. Expiratory accentuation (_>40% com- 
pared with inspiration) of hepatic vein (HV) diastolic flow reversal is one important 
diagnostic feature of CP. However, it is not clear whether this feature is obfuscated by the 
presence of severe tricuspid regurgitation (TR), which causes HV systolic flow reversal. 
The purpose of this study was to characterize the 2D and Doppler echocardiographic 
features of CP in the presence of severe TR. 
Methods. From 1985 to 2000, 9 patients (age 66 + 9, 67% male) with surgically con- 
firmed constrictive pericarditis and severe TR (grade 3 or 4) underwent comprehensive 
hemodynamic evaluation by echocardiography preoperatively. 
Results. Three patients (33%) were in atdal fibdllation, the remaining were in sinus 
rhythm (67%). Left ventricular ejection fraction was 59 :t: 10%. 2D findings included char- 
acteristic ventricular septal bounce in 8 patients (89%), thickened pericardium in 6 (67%), 
and dilated inferior vena cava in all patients. Estimated pulmonary artery systolic pres- 
sure was 42 ± 10 mm Hg. Analysis of mitral inflow Doppler patterns demonstrated respi- 
ratory variation of mitral E wave velocity > 25% in 5 of g patients (56%) and shortened 
deceleration times of 141 ± 43 ms and 164 ± 41 ms (inspiration and expiration, respec- 
tively). HV Doppler analysis revealed HV systolic flow reversal in 8 patients (89%) and 
HV diastolic forward flow decrease during expiration in all patients (100% with a mean 
decrease of 35%). Prominent HV diastolic flow reversal accentuation with expiration was 
only seen in 2 (22%) patients. 
Conclusion. In patients with CP and severe TR: 1 ) typical 2D features of CP are present 
in most patients; 2) mitral inflow velocity patterns are similar to those observed in CP 
patients without severe TR; and 3) diagnostic expiratory increase of HV diastolic flow 
reversal is usually not present. 
1038-149 Electrocardiographic Findings in Patients With 
Arrhythmogenic Right Ventricular Cardlomyopathy and 
Idiopathic Ventricular Tachycardia: Potential Role for 
Risk Strat i f i cat ion?  
Matthias Paul, Hans-Juergen Bruns, Guenter Breithardt, Thol~as Wichter, University of 
Muenster, Department of Cardiology, Muenster, Germany. 
Backoround: Both patients (pts) with arrhythmogenic right ventricular cardiomyopathy 
(ARVC) and idiopathic ventricular techycardia or fibrillation (IVT) clinically present with 
ventricular tachyarrhythmias, syncope, or cardiac arrest. We assessed the diagnostic 
value of different ECG parameters for the electrocardiographic distinction between ARVC 
and IV'I" and their potential role for risk stratification. 
Methods: 12-lead surface ECG of 76 pts with ARVC (mean age 39.5 +/- 15.4 yrs) and 44 
pts with IVT (mean age 39.2 +/- 14.3 yrs) were analysed for the maximal duration of the 
QRS-complex (QRSmax), QRS dispersion (QRSdisp), sum of QRS durations in leads 
V1-3 (QRS'V1-3) and the ratio of QRS durations in right (QRS-V1.3) and left (QRS-V4_s) 
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precordial leads (QRS-V1. 3 / V4-s). These parameters were compared to the clinical 
events sudden death (7 pts; 5.8%), resuscitated cardiac arrest (21 pta; 17.5%) and 
inducibility of sustained ventricular tachycardia during electrophysiological study (65 pts; 
71.4%). 
Results: QRS-V1. 3 was the strongest predictor of venthcular techycardia inducibility 
(specificity 65%, sensitivity 75%, p<0.0O4). The ratio of summed QRS durations QRS.V 1. 
3 / V4-6 also showed a significant correlation with inducibility for both ARVC (p<O.003) 
and IVT pts (p<0.022). In ARVC pts with a history of sudden death/cardiac arrest (n=20), 
QRSmax was longer when compared to pts without such an event (121.3 +/- 12.6ms vs. 
115.4 ± 18.1 ms; p<0.05). In contrast to resuscitated patients with idiopathic venthcular 
fibrillation (n=6), QRS-V1. 3 showed a trend towards a longer duration in ARVC pts but did 
only reach bordedine significance (329.4 +/- 42.4ms vs. 290.0~.46.6ms; p<0.059). 
Conclusions: In pts with ARVC, the 12-lead ECG parameter QRSmax appears to be 
correlated with an increased dsk of sudden death or cardiac arrest. Our data indicate the 
potential role of QRS-V 1.3 analysis as a quickly available tool to predict the inducibility of 
ventricular tachyarrhythmias during electrophysiological study in pts with ARVC and IVT. 
Further investigations are required to identify threshold levels, which was not possible in 
the present study due to the limited number of pts. 
1038-150 A Novel Lamin A/C Miasense Mutat ion  In a Fami ly  With 
Autosomal Dominant Dilated Cardiomyopathy With 
Conduction Abnormalities 
Rvuichiro Anan, Hideshi Niimura, Takeshi Sasaki, J. G. Seidman, Christine E. Seidman, 
Shinichi Minagoe, Chuwa Tel, Kagoshima University, Kagoshima, Japan, Harvard 
Medical School, Boston, Massachusetts. 
Background: Dilated cardiomyopathy is a form of heart muscle disease characterized by 
impaired systolic function and ventricular dilatation. Familial inheritance is observed in 
approximately 30 % of cases with dilated cardiomyopathy. Recent studies have shown 
that mutations in the lamin NC gene could cause four different autosomal dominant 
inherited disorders: familial dilated cardiomyopathy with preceding conduction system 
diseases, Emery-Dreifuss muscular dystrophy, limb-girdle muscular dystrophy tybelB, 
and familial partial lipodystrophy. Mutations that encode the helical rod 1 domain or the 
globular tail region of lamin NC protein cause familial dilated cardiomyopathy. Methods: 
We studied six families with autosomal dominant dilated cardiomyopathy. Four families 
were associated with conduction abnormalities. Direct sequence analyses for coding 
regions of lamin NC pone were performed in the probands of the six families. Results: A 
novel lamin NC gene mutation was found in a prebend with familial dilated cardiomyopa- 
thy associated with conduction abnormalities. The mutation is a missense mutation, 
which changes arginine to tryptophan at codon 190 (Arg190Trp) in exon 3 in the lamin N 
C gene. This change encodes the amino acid located in the helical rod 1 portion of lamin 
NC protein. Electrocardiogram of the proband showed first degree atdo-ventricular block 
and complete dght bundle branch block. Echocardiogram of the prebend showed diffuse 
hypokinetic motion of the left ventricle. The left ventricular diastolic dimension was 64 
mm, and the fractional shortening was 0.09. The prebend died of congestive heart failure 
at age of 48. In this family, dilated cardiomyopathy was diagnosed in six individuals. Five 
affected individuals died of congestive heart failure. The mean age of deaths was 50-J:3 
years. These results predict an incidence of lamin NC mutation in approximately one 
fourth of individuals with dilated cardiomyopathy associated with conduction system dis- 
ease. Conclusion: A novel missense mutation (Arg190Trp) in the lamin NC gene was 
detected in a family with dilated cardiomyopathy associated with conduction abnormali- 
ties. 
1038-151 Reorganizat ion  of  the Cardiac Gap Junctions in 
Adrlamycin-lnduced Cardiomyopathy 
Gabriele Plenz. Volker Arps, Eschert Heike, Stafan Christiansen, Joerg Stypmann, Uldch 
Jahn, Marie C. Deng, Hans H. Scheld, Dieter Hammel, Hospital of Muenster Universi~ 
Muenster, Germany, Institute for Arteriosclerosis Research, Muenster, Germany. 
Background: Gap junctions mediate the propagation of the electrical impulse between 
cardiac myocytes. The connexins (Cx) constituting the cardiac gap junctions are Cx43, 
Cx40 and Cx45. In normal human hearts Cx43 is homogeneously distributed in all cham- 
bers, while Cx40 is more abundant in atria. In advanced heart failure alterations of the Cx 
patterns are found. We hypothesized that adriamycin-inducad cardiomyopathy is accom- 
panied by a reorganization of the Cx patterns analogous to that reported for dilated cardi- 
omyopathy. 
Methods: In FBI dogs (30-35 kg) the development of a cardiomyopathy was induced 
using repetitive intracoronary administration of adriamycin (10 rag/50 ml saline over 1 h 
per week) through a silicone-catheter insertion. Transmural left ventricular biopsies were 
taken after catheter insertion (control) and 4 weeks after addamycin administration. 
mRNA was analyzed by RT-PCR for Cx43, Cx40 and Cx45. 
Results: In normal canine hearts only Cx43 was detected. Adriamycin administration led 
changes in LVEDD and FS. Moderate changes (hypertrophy = HY; LVEDD: 0.21t"0.21 
over control; FS: 70.65+3.7% of control) were associated with increased Cx43 levels 
(2.46fold) and an induction of Cx40. With further deterioration of cardiac function (cardi- 
omyopathy = CM; LVEDD: 0.67:L-0.05 over control; FS: 46.45+3.61% of control) Cx pat- 
terns changed again. Cx43 levels decreased (8.2fold), Cx40 levels remained elevated 
and Cx45 was induced. 
Conclusions: The present study suggests that repetitive intracoronary addamycin admin- 
istration resulted in a stepwise detedoration of cardiac function. Concomitantly the con- 
nexin patterns changed. First patterns were found as reported for HY in small animal and 
humans and consecutively patterns as described for dilated CM in humans. The present 
data indicate that adriamycin administration induces dilated CM in dogs and therefore is 
a suitable model to study the effects on the propagation of the electrical impulse after 
surgical treatment strategies of DCM such as partial left ventriculectomy. (Deutsche Stif- 
tung for Herzforschung, Frankfurt) 
